Free Trial

JB Capital Partners LP Makes New $365,000 Investment in Varex Imaging Co. (NASDAQ:VREX)

Varex Imaging logo with Medical background
Remove Ads

JB Capital Partners LP acquired a new position in shares of Varex Imaging Co. (NASDAQ:VREX - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 25,000 shares of the company's stock, valued at approximately $365,000. JB Capital Partners LP owned about 0.06% of Varex Imaging at the end of the most recent reporting period.

Other hedge funds also recently modified their holdings of the company. KLP Kapitalforvaltning AS acquired a new position in Varex Imaging during the fourth quarter worth $98,000. US Bancorp DE grew its position in shares of Varex Imaging by 149.8% in the 4th quarter. US Bancorp DE now owns 7,386 shares of the company's stock valued at $108,000 after acquiring an additional 4,429 shares during the period. New York State Common Retirement Fund increased its stake in shares of Varex Imaging by 60.7% during the 4th quarter. New York State Common Retirement Fund now owns 9,531 shares of the company's stock worth $139,000 after purchasing an additional 3,600 shares during the last quarter. Aigen Investment Management LP bought a new stake in shares of Varex Imaging in the 4th quarter valued at about $147,000. Finally, Inceptionr LLC bought a new stake in shares of Varex Imaging in the 4th quarter valued at about $168,000.

Varex Imaging Stock Performance

NASDAQ:VREX traded down $0.01 during mid-day trading on Wednesday, hitting $7.45. 217,287 shares of the stock were exchanged, compared to its average volume of 462,236. The firm's 50-day simple moving average is $12.43 and its 200 day simple moving average is $13.35. The stock has a market capitalization of $306.94 million, a price-to-earnings ratio of -6.37 and a beta of 0.65. Varex Imaging Co. has a fifty-two week low of $7.32 and a fifty-two week high of $18.17. The company has a debt-to-equity ratio of 1.02, a quick ratio of 2.50 and a current ratio of 4.36.

Remove Ads

Varex Imaging (NASDAQ:VREX - Get Free Report) last posted its earnings results on Thursday, February 6th. The company reported $0.07 earnings per share for the quarter, topping analysts' consensus estimates of $0.04 by $0.03. Varex Imaging had a positive return on equity of 4.00% and a negative net margin of 5.79%. As a group, equities analysts anticipate that Varex Imaging Co. will post 0.53 EPS for the current fiscal year.

Insiders Place Their Bets

In related news, CEO Sunny Sanyal sold 8,749 shares of Varex Imaging stock in a transaction that occurred on Wednesday, April 2nd. The shares were sold at an average price of $11.24, for a total value of $98,338.76. Following the transaction, the chief executive officer now directly owns 190,193 shares of the company's stock, valued at $2,137,769.32. This trade represents a 4.40 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, SVP Kimberley E. Honeysett sold 4,007 shares of the company's stock in a transaction on Thursday, March 20th. The stock was sold at an average price of $12.81, for a total value of $51,329.67. Following the sale, the senior vice president now owns 4,002 shares of the company's stock, valued at $51,265.62. The trade was a 50.03 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 4.30% of the company's stock.

Wall Street Analysts Forecast Growth

A number of equities analysts have weighed in on VREX shares. StockNews.com raised Varex Imaging from a "hold" rating to a "buy" rating in a research report on Friday, February 7th. B. Riley restated a "buy" rating and issued a $22.00 price target (up previously from $21.00) on shares of Varex Imaging in a research note on Friday, February 7th. Finally, Oppenheimer reduced their price objective on shares of Varex Imaging from $30.00 to $23.00 and set an "outperform" rating for the company in a research report on Friday, February 7th.

Check Out Our Latest Analysis on VREX

Varex Imaging Profile

(Free Report)

Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components. The company operates through two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components, comprising X-ray tubes, digital detectors and accessories, ionization chambers, high voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and heat exchangers.

Read More

Institutional Ownership by Quarter for Varex Imaging (NASDAQ:VREX)

Should You Invest $1,000 in Varex Imaging Right Now?

Before you consider Varex Imaging, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Varex Imaging wasn't on the list.

While Varex Imaging currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

5 International Stocks to Escape U.S. Market Volatility

5 International Stocks to Escape U.S. Market Volatility

MarketBeat’s Chris Markoch shares 5 international stock picks that could offer protection—and potential opportunity—amid the current market uncertainty.

Related Videos

Donald Trump Owns These 7 Stocks, Should You?
 5 Stocks to BUY NOW in April 2025
3 Chip Stocks Primed for a Comeback—Have They Found the Bottom?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads